Search hospitals > New Mexico > Albuquerque
Albuquerque Clinical Trials, Inc.
Claim this profileAlbuquerque, New Mexico 87102
Global Leader in Migraine
Global Leader in Arthritis
Conducts research for Rheumatoid Arthritis
Conducts research for Osteoarthritis
Conducts research for Type 2 Diabetes
119 reported clinical trials
4 medical researchers
Summary
Albuquerque Clinical Trials, Inc. is a medical facility located in Albuquerque, New Mexico. This center is recognized for care of Migraine, Arthritis, Rheumatoid Arthritis, Osteoarthritis, Type 2 Diabetes and other specialties. Albuquerque Clinical Trials, Inc. is involved with conducting 119 clinical trials across 73 conditions. There are 4 research doctors associated with this hospital, such as Satkirin K Khalsa, Marigene Sharma, MD, Marigene Salazar Sharma, and Kim, Ellen.Area of expertise
1Migraine
Global Leader2Arthritis
Global LeaderRheumatoid factor positive
Anti-cyclic citrullinated peptide autoantibodies positive
Top PIs
Satkirin K KhalsaAlbuquerque Clinical Trials, Inc.1 year of reported clinical research
Studies Arthritis
Studies Connective Tissue Disease
4 reported clinical trials
6 drugs studied
Marigene Sharma, MDAlbuquerque Clinical Trials, Inc3 years of reported clinical research
Studies Birth Control
Studies Migraine
3 reported clinical trials
3 drugs studied
Marigene Salazar SharmaAlbuquerque Clinical Trials, Inc.1 year of reported clinical research
Studies Migraine
Studies Arthritis
2 reported clinical trials
3 drugs studied
Kim, EllenAlbuquerque Clinical Trials, Inc.2 years of reported clinical research
Studies Celiac Disease
1 reported clinical trial
1 drug studied
Clinical Trials running at Albuquerque Clinical Trials, Inc.
Migraine
Type 2 Diabetes
Flu
Systemic Lupus Erythematosus
Lupus
Irritable Bowel Syndrome
Graves Disease
Recurrence
Celiac Disease
Rimegepant
for Migraine Prevention
This study is being conducted to evaluate the efficacy and tolerability of rimegepant for migraine prophylaxis in adults with a history of inadequate response to oral preventive medications
Recruiting2 awards Phase 41 criteria
Ubrogepant
for Migraine
A migraine is a moderate to severe headache typically on one side of the head. A migraine attack is a headache that may be accompanied by throbbing, nausea, vomiting, sensitivity to light and sound, or other symptoms. Menstrual migraine (MM) is defined as migraine attacks that occur within the perimenstrual period (PMP) in at least 2 out of 3 menstrual cycles. The PMP is from 2 days before the onset of menstrual bleeding to 2 days after. This study will assess how safe and effective ubrogepant is in treating menstrual migraine. Adverse Events and change in disease activity will be assessed. Ubrogepant is an investigational drug being developed for short-term prevention of menstrual migraine. Participants will be randomly assigned to one of the 2 groups to receive either ubrogepant or placebo. Around 450 adult female participants with menstrual migraine will be enrolled in approximately 85 sites in the United States and Puerto Rico. Participants will receive oral ubrogepant tablets once daily for 7 consecutive days starting 3 days prior to estimated onset of menses per cycle for 3 PMPs during double-blind period (16 weeks). Eligible participants may continue to receive oral ubrogepant tablets once daily for 7 consecutive days per cycle starting 3 days prior to estimated onset of menses during open-label extension period (52 weeks). There may be higher treatment burden for participants in this trial compared to their standard of care. Participants will collect data daily in electronic diaries and attend regular visits during the study at a hospital or clinic. The effect of the treatment will be checked by medical assessments, blood tests, checking for side effects and completing questionnaires.
Recruiting1 award Phase 33 criteria
BOTOX Injections
for Migraine
This study is evaluating whether a treatment for migraine can prevent migraine attacks in adults with episodic migraine.
Recruiting1 award Phase 34 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Albuquerque Clinical Trials, Inc.?
Albuquerque Clinical Trials, Inc. is a medical facility located in Albuquerque, New Mexico. This center is recognized for care of Migraine, Arthritis, Rheumatoid Arthritis, Osteoarthritis, Type 2 Diabetes and other specialties. Albuquerque Clinical Trials, Inc. is involved with conducting 119 clinical trials across 73 conditions. There are 4 research doctors associated with this hospital, such as Satkirin K Khalsa, Marigene Sharma, MD, Marigene Salazar Sharma, and Kim, Ellen.